Rapid Readouts: The Phase 1/2 ANCHOR Trial for Melphalan Flufenamide in Relapsed/Refractory Multiple Myeloma

Video

Related Videos
Sundar Jagannath, MBBS
Elias Jabbour, MD
Guenther Koehne, MD, PhD
Joseph G. Jurcic, MD
Krina K. Patel, MD, MSc
Ibrahim Aldoss, MD
Minoo Battiwalla, MD
Sundar Jagannath, MBBS
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center